Please assess the completion status of the following clinical trial:

Trial Title: Tamsulosin as Adjuvant Treatment Prior to Endoscopic Ureterolithotomy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with urolithiasis undergoing to endoscopic ureterolithotomy~Exclusion Criteria:~* Patients with previous ureteral catheter~  * Patients with allergy to tamsulosin~ * Patients currently in treatment with tamsulosin for other disease different than ureterolithiasis~ * Multiple ureterolithiasis~ * Patients with impairment of their mental status~    * Patients with open surgeries in the affected ureter or urinary diversion~   * Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- tamsulosin hydrochloride (Type: EXPERIMENTAL): Tamsulosin hydrochloride 0,4 mg tablets by mouth per day for 5 days before ureteroscopy
- Placebo oral tablet (Type: PLACEBO_COMPARATOR): Placebo oral tablets by mouth per day for 5 days before ureteroscopy

Based on this trial design, predict the completion outcome and termination type (if applicable).